Stockscreener 앱 받기
16.14
0.58%
-0.095
Viatris Inc 주식(VTRS)의 최신 뉴스
Viatris reports positive phase 3 results for IgAN drug in Japan By Investing.com - Investing.com India
(VTRS) Risk Channels and Responsive Allocation - Stock Traders Daily
How is Viatris’ stock performance compared to other healthcare stocks? - MSN
Viatris reports positive Japanese phase 3 results for Nefecon in IgAN - MSN
Viatris' VR-205 Meets Primary, Key Secondary Endpoints in Japanese Phase 3 Trial in Kidney Disease - marketscreener.com
Viatris reports positive phase 3 results for IgAN drug in Japan - Investing.com
Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy - PR Newswire
Join Class Action to Recover Losses from Viatris Inc. (VTRS)Contact Levi & Korsinsky Before June 3, 2025 - The National Law Review
Enterprise value to EBITDA forward of Viatris Inc. – NASDAQ:VTRS - TradingView
Viatris interim CFO Paul Campbell sells $809,784 in stock By Investing.com - Investing.com South Africa
Viatris interim CFO Paul Campbell sells $809,784 in stock - Investing.com UK
Form 4 Viatris Inc For: 26 June By Investing.com - Investing.com South Africa
Enterprise value to revenue forward of Viatris Inc. – NASDAQ:VTRS - TradingView
Viatris Inc. stock rises Friday, outperforms market - MarketWatch
Planned sale: Viatris (VTRS) officer disposes 50,076 shares - Stock Titan
Viatris | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Viatris, Inc. Actuals & Estimates (FWB:VIA) - TradingView
Price to sales forward of Viatris Inc. – NASDAQ:VTRS - TradingView
Viatris, Inc. Actuals & Estimates (SWB:VIA) - TradingView
Viatris, Inc. Actuals & Estimates (BMV:VTRS) - TradingView
Viatris Inc (VTRS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Viatris, Inc. Actuals & Estimates (DUS:VIA) - TradingView
Form 144 Viatris Inc For: 25 June By Investing.com - Investing.com Nigeria
Viatris (VTRS) Rule 144 notice lists 49,715 vested shares and other entries - Stock Titan
VTRS Forecast — Price Target — Prediction for 2027 - TradingView
Viatris Inc. stock rises Wednesday, outperforms market - MarketWatch
How Viatris’ €650 Million Eurobond Issue (VTRS) Has Changed Its Investment Story - simplywall.st
Viatris Inc. stock rises Tuesday, outperforms market - MarketWatch
Viatris Soared 54%: Time To Be More Careful (Rating Downgrade) (NASDAQ:VTRS) - Seeking Alpha
Are Investors Undervaluing Viatris (VTRS) Right Now? - Yahoo Finance
Viatris (VTRS) Q4 2025 Earnings Call Transcript - Fortune
Viatris Inc. (VTRS) Investor Outlook: Is The 15.89% Potential Upside Worth The Risk? - DirectorsTalk Interviews
Come As You Are: Emily Smith Builds Solidarity, Support for LGBTQ+ Colleagues Through VIVID - CSRwire
How Is Viatris’ Stock Performance Compared to Other Healthcare Stocks? - Barchart.com
Viatris Inc. stock falls Thursday, underperforms market - MarketWatch
Viatris Issues €650 Million Senior Notes to Refinance Debt - TipRanks
Viatris Completes €650 Million 4.250% Senior Notes Due 2033 to Refinance 2026 Debt - TradingView
Viatris (NASDAQ: VTRS) issues €650M 4.25% notes to help refinance 2026 debt - Stock Titan
(VTRS) Movement as an Input in Quant Signal Sets - Stock Traders Daily
XS332542958 Bond Price and Chart — FWB:XS332542958 - TradingView
Viatris Inc (VTRS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Viatris Inc. stock falls Wednesday, underperforms market - MarketWatch
Viatris Inc (VTRS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Viatris Inc (VTRS) Institutional Confidence - TradingKey
Viatris Inc. stock falls Tuesday, underperforms market - MarketWatch
Viatris Recognized as One of the 2026 Best Workplaces™ in Canada - Yahoo Finance
Viatris Issues €650 Million Senior Notes in Europe - TipRanks
Viatris launches €650M 4.250% senior notes due 2033 offering - TradingView
Viatris (VTRS) prices €650M 4.250% senior notes maturing 2033 - Stock Titan
Viatris (VTRS) sells €650M 4.25% senior notes to refinance 2026 debt - Stock Titan
Euro Bond Sale Might Change The Case For Investing In Viatris (VTRS) - simplywall.st
Viatris Inc. (VTRS) Stock Analysis: Navigating Growth Prospects with an 8.09% Potential Upside - DirectorsTalk Interviews
Viatris (VTRS) Stock And The 58% Undervaluation Debate After A Strong Year Of Returns - Yahoo Finance
Viatris Euro Debt Raise Reshapes Capital Structure And Valuation Story - Yahoo Finance
0.49%
2.05%
자본화:
|
볼륨(24시간):